Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models. [electronic resource]
Producer: 20190319Description: 1084-1094 p. digitalISSN:- 1478-3231
- Alanine Transaminase -- blood
- Animals
- Aspartate Aminotransferases -- blood
- Biomarkers -- blood
- Diet, High-Fat
- Fenofibrate -- pharmacokinetics
- Hep G2 Cells
- Humans
- Kupffer Cells -- drug effects
- Liver -- pathology
- Male
- Mice
- Mice, Inbred C57BL
- Non-alcoholic Fatty Liver Disease -- drug therapy
- PPAR alpha -- agonists
- Phenylpropionates -- pharmacology
- Pioglitazone -- pharmacology
- Pyrroles -- pharmacology
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.